At a glance
ClinicalIndex Comparison RecordN/ACompleted· 60 enrolled
Drug / intervention
ERAS pathway +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomized Control Trial to Compare the Outcomes of Enhanced Recovery After Surgery (ERAS) Pathway and Standard Recovery Pathway After Laparoscopic Sleeve Gastrectomy
In Brief
A clinical study evaluating ERAS pathway and Standard pathway for Morbid Obesity. Completed, enrolled 60 participants across 1 site.
Detailed Summary
The aim of this study is to compare two postoperative recovery pathways namely, enhanced recovery after surgery (ERAS) pathway and conventional recovery pathway after laparoscopic sleeve gastrectomy with respect to outcomes including hospital stay, postoperative pain and other postoperative outcomes.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMorbid Obesity
CountriesIndia
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedJun 2017
Enrollment StartSep 2017
Primary CompletionJul 2018
Study CompletionAug 2018
TodayJul 2026
First PostedJun 19, 2017
Enrollment StartSep 1, 2017
Primary CompletionJul 1, 2018
Study CompletionAug 1, 2018
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 9.0 years ago
Interventions
ERAS pathwayother
ERAS pathway after laparoscopic sleeve gastrectomy
Standard pathwayother
Standard pathway after laparoscopic sleeve gastrectomy